🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the potential pharmacokinetic interactio...
Status
Terminated
Location
GSK Investigational Site
Start Date
2005-08-10
Trial ID
NCT00334646
Treatments Being Tested
This a Phase III trial designed to determine if IV casopitant plus dexameth...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-03-10
Trial ID
NCT00601172
Treatments Being Tested
This study is being conducted to see if adding GW679769 (casopitant) to ZOF...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-03
Trial ID
NCT00334152
Treatments Being Tested
GW679769 may affect liver enzymes that metabolize dexamethasone and ondanse...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-19
Trial ID
NCT00437229
Treatments Being Tested
This is a Phase III trial designed to demonstrate that casopitant when adde...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-11-06
Trial ID
NCT00431236
This is a Phase III trial designed to demonstrate that casopitant (GW679769...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-07
Trial ID
NCT00366834
This study is looking at a range of doses of this NK-1 receptor antagonist ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-10
Trial ID
NCT00108095
Treatments Being Tested
This is a phase III study designed to demonstrate the superiority of single...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2009-09
Trial ID
NCT00891761
Treatments Being Tested
The primary purpose of this study is to determine an effective dose of this...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-02
Trial ID
NCT00274690
Treatments Being Tested